Sanjivani Paranteral Ltd Falls 2.39%: 2 Key Developments Shaping the Week
2026-11-22 10:00:09Key Events This Week 16 Nov: Valuation turns very attractive amid market pressure 19 Nov: MarketsMOJO upgrades rating to Buy on improved fundamentals 20 Nov: Stock closes at Rs.167.10, down 3.44% on the day Week OpenRs.171.20 Week CloseRs.167.10-2.39% <div class="sta...
Read More
Sanjivani Paranteral Ltd Upgraded to Buy on Improved Technicals and Financials
2026-11-20 08:02:23Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Hold to Buy by MarketsMojo as of 19 Nov 2026. This upgrade reflects a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. The company’s improved technical indicators, fair valuation metrics, and robust financial performance underpin this positive outlook despite some near-term challenges.
Read More
Sanjivani Paranteral Ltd Valuation Turns Very Attractive Amid Market Pressure
2026-11-16 08:00:30Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a fair to a very attractive rating. This change reflects a significant reassessment of the company’s price attractiveness relative to its historical averages and peer group, despite recent stock price softness and sector headwinds.
Read More
Sanjivani Paranteral Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-11-13 08:03:30Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 12 Nov 2026. This adjustment reflects a nuanced reassessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong quarterly financials and operational efficiency, the stock’s technical indicators and relative valuation have prompted a more cautious stance.
Read More
Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO
2026-10-28 10:10:44Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Sanjivani Paranteral Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-10-27 08:00:24Sanjivani Paranteral Ltd has witnessed a significant improvement in its valuation parameters, shifting from a fair to a very attractive rating. This change comes amid a challenging market backdrop where the stock has underperformed the Sensex over recent periods, yet shows compelling long-term returns and a favourable valuation relative to its pharmaceutical peers.
Read More
Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO
2026-10-17 10:10:05Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 October 2026, providing investors with the most recent insights into its performance and outlook.
Read More
Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment
2026-10-16 08:00:21Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, reflecting evolving market perceptions amid mixed financial signals. This micro-cap pharmaceutical player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have risen significantly, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.
Read More
Sanjivani Paranteral Ltd is Rated Hold by MarketsMOJO
2026-10-06 10:10:03Sanjivani Paranteral Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 October 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read MoreRegulation 30 For In-Principle Approval
07-Nov-2026 | Source : BSERegulation 30 for In-Principle approval
Announcement under Regulation 30 (LODR)-Investor Presentation
06-Nov-2026 | Source : BSEInvestor Presentation for the Quarter ended 30th September 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSENewspaper Publication for the financial results ended 30th September 2026
Corporate Actions
No Upcoming Board Meetings
Sanjivani Paranteral Ltd has declared 5% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available